Speaker(s):

Ned Presnall, MSW, LCSW and Robert Riley II, MAADC II

Presentation: For at least a decade, we have been training front-line substance abuse counselors in the science of addiction and Medication Assisted Treatment (MAT). Many counselors have come to understand that effective treatment for opioid dependence starts with medication. Yet, lack of access to maintenance pharmacotherapy remains a major contributor to our rising overdose rate. This presentation will look at the system-level barriers to treatment access and propose effective and cost-effective models of treatment that can be used to improve access to treatment on a large scale. The presenter will argue that even without additional financial resources to fight OUD we could be using the resources we already have to begin reversing the overdose epidemic.

Objectives:

• Explain which approaches to OUD are best supported by research.
• Review cost-effective and scalable models of OUD treatment with potential to reverse the opioid epidemic, e.g. models that can be implemented in primary care.
• Describe the barriers to implementing these models and initial strategies to overcome them.

 

 

 

 

 

 

 

 

 

 

 

 

 

Speaker(s):

A. Benjamin Srivastava, MD

Presentation: This will be a didactic presentation with audience engagement regarding practical issues with medication assisted treatment in addiction practice.

Objectives:

• Describe the rationale for pharmacotherapy in addiction treatment
• Explain reasons for under utilization
• Promote evidence based practices

Slides:

Srivastava_DMHSpringTraining2017

 

 

 

 

 

 

 

 

 

 

Speaker(s):

Rick Strait, MS, LPC, Heather Williams, BS and Scott Kerby, MA, LPC

Presentation: Our presentation will cover practical tips on how to into incorporate medication assisted treatment (MAT) into your treatment. We will give examples of what MAT is and what MAT is not, and that education is power, both for the professional and the consumer. We will share some of the obstacles we had to overcome and are still overcoming when we first starting encouraging MAT in our co-occurring program. These barriers included educating consumers, educating doctors, as well as dealing with resistance from other staff members and some support groups. We will give examples on helping to determine if someone would benefit from MAT, helping the consumer communicate with doctor about MAT, and how to use Motivational Interviewing to help consumers who may benefit from MAT, but that are struggling with ambivalence. We will give examples of overcoming personal biases towards MAT and how to be an advocate/educator of MAT at your agency. We also will cover how MAT can be a wonderful part of a consumer’s treatment, but that it is not a cure in of itself; providing tips to help encourage and keep consumers engaged, who may feel like they no longer need counseling because they have MAT.

Objectives:

• Suggest different tips or ways to roll with resistance and educate on MAT (prescribers, staff, families, consumers, etc.)
• Summarize how to continue to use motivational interviewing and outreach with consumers who are using MAT and no longer feel they need other parts of treatment.
• Review facts about what MAT is and how to use that information to help reduce discrimination towards MAT.